September 26, 2024
Adding immunotherapy to standard chemotherapy keeps most patients with B-cell acute lymphoblastic leukemia in remission and improves their survival
January 5, 2023
Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival
June 28, 2022
This trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment
March 24, 2022
Summaries of recently reported ECOG-ACRIN research results